Journal decision profile

Biochimica Et Biophysica Acta-Molecular Basis of Disease

Medicine · Biochemistry, Genetics and Molecular Biology

Biochimica Et Biophysica Acta-Molecular Basis of Disease's 2026 Journal Metrics Score is 4.6, ranking Q1 in Physiology. Two-year citation average from OpenAlex data, updated August 2026.

Elsevier BVNetherlandspISSN 0925-4439eISSN 1879-260X
Checking system sharing availability.Visit homepage

Bookmark this page — track observed submission-to-acceptance timing, FWCI and field-normalized citation data for this journal in one view.

Journal Metrics Score
i
Journal Metrics ScoreThe raw score is citations received in the latest complete year by works from the two previous years, divided by the number of those works. It is calculated from OpenAlex open data (CC0) and is not a percentage grade.
2026
4.6

Journal Metrics Score 2026 · 2021–2024 window citedness 4.91.

Review & acceptance time
i
Review & acceptance timeCalendar days between the received and accepted dates reported in recent PubMed records. This interval includes editorial handling and author revisions, so it is not time to first decision or pure peer-review time.
PUBMED
138 daysmedian

Middle 50%: 109–203 days

99 of 100 PubMed-indexed articles · 99% coverage · 2024–2025

Biochimica Et Biophysica Acta-Molecular Basis of Disease accepts papers a median of 138 days after submission, including peer review and revisions. That is slower than 72% of comparable journals with PubMed timing data.

Indicative APC
i
Indicative APCThis journal-level estimate comes from the OpenAlex source record. It is not a verified quote and may exclude taxes, waivers, society discounts, or article-type charges. Check the journal's official website before deciding.
OPENALEX · VERIFY
$3,660

Journal-level estimate only. Verify current charges, taxes, waivers, discounts, and article-type fees with the journal.

Free preview · no sign-in

Does your manuscript fit Biochimica Et Biophysica Acta-Molecular Basis of Disease?

Paste your title to see which of this journal's published topics it overlaps with. Your title stays in your browser for this preview and is not sent anywhere.

Want ranked journals with fit reasons, risks and a submission strategy instead? See a sample AI report.

At a glance

Journal decision profile

Each spoke is a 0–100 percentile within a comparable journal cohort—not a percentage grade or a single black-box rating.

Relative profile

Metrics ScoreThe raw 2026 Journal Metrics Score is the recent two-year citation average shown above. The radar converts it to a 0–100 cohort percentile: farther out means a higher score than more comparable journals. It is not a percentage grade.iSource outputThe raw rank compares lifetime output inside the journal’s leading-topic source set. The radar then compares that rank position across Decision Profile journals in the same primary OpenAlex field; when that field has too few profiles, it uses the broader profile set. Farther out means relatively more output, not better research quality.iTop 10% shareThe share of recent papers in the global top 10% for citations after comparing papers of the same type, publication year, and subfield. The radar converts that share to a 0–100 cohort percentile; it does not predict how a new paper will perform.iMedian FWCICitation performance of the middle recent paper after field, year, and work type are considered. A raw FWCI of 1.0 is the expected citation level for comparable papers; the radar shows its 0–100 cohort percentile.iSubmission-to-acceptanceCalendar days from the received date to the accepted date in recent PubMed records. This includes editorial handling and author revisions, so it is not the time to first decision and not pure peer-review time. The radar uses a 0–100 cohort percentile with shorter observed timing plotted farther out; it does not measure review quality.iOutput volumeAverage works published per year in the recent analysis window, converted to a 0–100 cohort percentile. Farther out means the journal publishes more papers; it does not mean those papers are better.i
Cost is intentionally excluded. Missing APC data is never converted to a zero-dollar fee or a fabricated cost score.

Raw values behind the shape

Always visible
Metrics Score
i
Metrics ScoreThe 2026 raw Journal Metrics Score shown above. The bar is its 0–100 percentile within the radar's comparable journal cohort; it is not a percentage score.
4.62026 · OPENALEX
Source output rank
i
Source output rankThis lifetime journal-wide output rank compares works published by the OpenAlex source with sources associated with the journal’s leading topic. More output does not mean higher quality.
#122 / 1,723LIFETIME OUTPUT
Highly cited papers
i
Highly cited papersShare of recent works in the global top 10% for citations after comparing papers of the same type, publication year, and subfield.
22.4%FIELD-NORMALIZED TOP 10%
Field-normalized impact
i
Field-normalized impactCitation performance of the middle recent paper after field, year, and work type are considered. A raw FWCI of 1.0 is the expected level for comparable work.
1.31MEDIAN FWCI
Submission-to-acceptance
i
Submission-to-acceptanceReceived-to-accepted calendar days from qualified PubMed records. It includes editorial handling and author revisions; it is not time to first decision or pure peer-review time.
138 daysIQR 109–203 DAYS
Recent output
i
Recent outputAverage works published per year across the complete analysis window. This is a volume measure, not a quality score.
324 / yr2021–2024 AVG
Field-normalized top 10% share22.4%

290 of 1,297 works · same type, year & subfield

Field-normalized top 1% share1.2%

15 works · same type, year & subfield

Median FWCI1.31×

Above field-year expectation

Source output rank#122

of 1,723 topic-associated OpenAlex sources by lifetime output

What does Median FWCI mean?

FWCI compares papers with the same publication year, type, and field. 1.0 is the world average; above 1.0 is above expectation. This journal's median is 1.31, so its typical recent paper runs about 31% above its field benchmark.

What does Top 10% Share mean?

22.4% of recent papers rank in the global top 10% after field normalization. This is easier to compare across specialties than raw citation totals.

Publishing pattern

Publication volume and article mix

Volume is separated from citation accumulation so newer papers are not presented as weaker simply because they are newer.

Works published by year

OpenAlex source records · 2016–2025

2622016
3852017
3712018
2632019
2852020
2022021
2132022
3082023
5742024
4342025

Recent work-type mix

1,297 OpenAlex works · 2021–2024

Article94.9%
Paratext3.1%
Erratum1.8%
Review0.2%
Editorial0.1%
OpenAlex article is broader than “original research.” PubMed Publication Types can add case-report and clinical-study detail.
Fit signals

Topics and medical subject coverage

OpenAlex topics show research communities; MeSH keeps the medical taxonomy recognizable.

Major MeSH signals

PubMed-indexed works

Select a MeSH signal to see how much Biochimica Et Biophysica Acta-Molecular Basis of Disease publishes on it, from PubMed counts for the last five complete years.

Leading OpenAlex topics

2021–2024 works
Mitochondrial Function and Pathology66
Diverse Scientific and Economic Studies40
Autophagy in Disease and Therapy35
Liver Disease Diagnosis and Treatment29
Cancer, Hypoxia, and Metabolism27
Adipose Tissue and Metabolism25
Ferroptosis and cancer prognosis24
RNA modifications and cancer23
Immune cells in cancer22
Extracellular vesicles in disease19
Methodology: OpenAlex snapshot 2026-08-12. FWCI, percentile badges, topics, and type mix use 1,297 works published 2021–2024. Radar normalization is versioned in the cached profile, and no cost score is assigned without reliable APC data.

Subject Category Quartiles

Quartiles computed within each OpenAlex subfield
CategoryQuartile
Molecular BiologyQ2
PhysiologyQ1

Is Biochimica Et Biophysica Acta-Molecular Basis of Disease a good journal?

Yes. A Q1 journal by citation data

Yes. By citation data, Biochimica Et Biophysica Acta-Molecular Basis of Disease is a strong journal: it is Q1 in Physiology and ranks #618 of 6,272 Medicine journals by Journal Metrics Score (top 10%). Biochimica Et Biophysica Acta-Molecular Basis of Disease's 2026 Journal Metrics Score is 4.6. Recent papers took a median of 138 days from submission to acceptance, according to PubMed dates. OpenAlex lists an indicative article processing charge of $3,660 USD. OpenAlex classifies its papers in subfields including Molecular Biology and Physiology, so check that your topic fits its scope.

Best quartile
Q1
Physiology
Rank in Medicine
#618 of 6,272
Top 10%
2026 Journal Metrics Score
4.6
Acceptance rate
Not published
By the journal or publisher
Submission to acceptance
138 days
Median, PubMed records
Indicative APC
$3,660
OpenAlex, verify with the journal
Papers published in 2025
434
OpenAlex works

Check before you submit

  • Its output more than doubled, from 213 papers in 2022 to 434 in 2025. Fast-growing journals can change in scope and editorial standards, so read recent papers in your topic.
  • Confirm the current article processing charge, waivers, and any institutional agreement on the journal website; the OpenAlex figure is indicative.
  • Confirm the journal is indexed where your institution or funder requires (for example Scopus or PubMed) before you submit.

Verdict from citation data only: quartile and field rank by Journal Metrics Score (OpenAlex), publisher-reported acceptance rates, and PubMed submission and acceptance dates. See how we rank journals and how to verify indexing.

Q1
Subfield Quartile
B2
CAS Block

Ranking and source check

#618
of 6,272 Medicine field journals
#618
among Q1 Medicine journals

Confirm the exact title and ISSNs against the publisher homepage before a high-stakes submission decision.

Journal Details

OpenAlex Works
7,250
H-Index
228
Fully Open Access
No
Recent OA Works
4,380
Subject Areas
Molecular BiologyEpidemiologyPhysiologyCancer Research

Source: the current OpenAlex source record. OpenAlex works can include multiple work types. Fully Open Access is a source-level flag. Recent OA Works is summed from OpenAlex's counts_by_year series (up to the latest ten years); it is not a lifetime OA percentage. Any APC shown here is an indicative OpenAlex value—verify current charges on the journal's official website.

How to submit to Biochimica Et Biophysica Acta-Molecular Basis of Disease

  1. 1

    Check the scope

    OpenAlex classifies Biochimica Et Biophysica Acta-Molecular Basis of Disease's papers in subfields including Molecular Biology and Physiology. Read the aims and scope page and a few recent papers close to your topic before you prepare the manuscript.

  2. 2

    Follow the author guidelines

    Article types, word and figure limits, reference style, and the required statements (data availability, ethics, conflicts of interest, author contributions) are set by the journal. Prepare the cover letter and files to match them.

    Biochimica Et Biophysica Acta-Molecular Basis of Disease homepage ↗
  3. 3

    Submit through Editorial Manager

    Most Elsevier and Cell Press journals take submissions through Editorial Manager; each journal has its own site, reached from Submit your article on the journal homepage.

  4. 4

    Plan for costs

    OpenAlex lists an indicative article processing charge of $3,660 USD. Check the current fee, waivers, and any institutional agreement on the journal website.

  5. 5

    Know what to expect

    Recent accepted papers took a median of 138 days from submission to acceptance, including revisions (PubMed dates). Biochimica Et Biophysica Acta-Molecular Basis of Disease does not publish an acceptance rate.

Submission system from the publisher's author information, checked 2026-10-27. Individual journals can differ, so follow the link in the journal's own author guidelines.

New on PubMed

What's new in your field?

Type a topic to see the newest PubMed papers from the past week and the big picture of what they found, summarized by Claude on the Pro plan. Get a free weekly email to keep up.

See a demo:GLP-1CRISPRLong COVID

Reviewer Two · coming soon

Know what reviewers will say before you submit to Biochimica Et Biophysica Acta-Molecular Basis of Disease

An AI pre-submission report on your manuscript: the objections a tough reviewer is likely to raise, desk-rejection risks, and better-fit journals from our data. $29 per report.

See what the report covers

Common questions about Biochimica Et Biophysica Acta-Molecular Basis of Disease

Is Biochimica Et Biophysica Acta-Molecular Basis of Disease a good journal?

Yes. By citation data, Biochimica Et Biophysica Acta-Molecular Basis of Disease is a strong journal: it is Q1 in Physiology and ranks #618 of 6,272 Medicine journals by Journal Metrics Score (top 10%). Biochimica Et Biophysica Acta-Molecular Basis of Disease's 2026 Journal Metrics Score is 4.6. Recent papers took a median of 138 days from submission to acceptance, according to PubMed dates. OpenAlex lists an indicative article processing charge of $3,660 USD. OpenAlex classifies its papers in subfields including Molecular Biology and Physiology, so check that your topic fits its scope.

What is Biochimica Et Biophysica Acta-Molecular Basis of Disease's Journal Metrics Score in 2026?

Biochimica Et Biophysica Acta-Molecular Basis of Disease's 2026 Journal Metrics Score is 4.6, from the August 2026 data release. The score is a two-year citation average computed from OpenAlex (CC0) data: citations received in the most recent complete year to works published in the two prior years, divided by the number of those works.

What is the acceptance rate of Biochimica Et Biophysica Acta-Molecular Basis of Disease?

We have not found an official acceptance rate published by Biochimica Et Biophysica Acta-Molecular Basis of Disease or its publisher, and Journal Metrics does not estimate one because submission counts are not public. What recent PubMed records do show is speed: accepted papers took a median of 138 days from submission to acceptance. To judge selectivity, compare Biochimica Et Biophysica Acta-Molecular Basis of Disease's quartile and score with similar journals, or ask the editorial office.

What quartile is Biochimica Et Biophysica Acta-Molecular Basis of Disease in?

Biochimica Et Biophysica Acta-Molecular Basis of Disease's best quartile is Q1. By OpenAlex subfield: Q2 in Molecular Biology; Q1 in Physiology. Quartiles rank journals by Journal Metrics Score within each subfield.

Is the Journal Metrics Score the same as other journal citation metrics?

No. Journal Metrics computes the score independently from OpenAlex open data. Other providers use different citation databases, document types, and counting rules, so their published figures for Biochimica Et Biophysica Acta-Molecular Basis of Disease will not match this score exactly. Compare journals using one source at a time.

How long does Biochimica Et Biophysica Acta-Molecular Basis of Disease take to accept a paper?

Biochimica Et Biophysica Acta-Molecular Basis of Disease accepts papers a median of 138 days after submission across 99 recent PubMed records with both dates; the middle half took 109–203 days. This includes peer review, editorial handling, and revisions.

How long is the peer review time at Biochimica Et Biophysica Acta-Molecular Basis of Disease?

PubMed records when a manuscript was received and accepted, not the individual review stages, so peer review time on its own is not available. The full time from submission to acceptance at Biochimica Et Biophysica Acta-Molecular Basis of Disease, which includes peer review and revisions, has a median of 138 days. For the time to a first decision, check the journal's own website.

Is Biochimica Et Biophysica Acta-Molecular Basis of Disease faster than similar journals?

Biochimica Et Biophysica Acta-Molecular Basis of Disease's median of 138 days from submission to acceptance is slower than 72% of comparable journals with PubMed timing data.

How much does it cost to publish in Biochimica Et Biophysica Acta-Molecular Basis of Disease?

OpenAlex lists an indicative article processing charge of $3,660 USD for Biochimica Et Biophysica Acta-Molecular Basis of Disease. This journal-level estimate may exclude taxes, waivers, discounts, or article-type fees, so confirm the current charge on the journal's website.

Which journals are alternatives to Biochimica Et Biophysica Acta-Molecular Basis of Disease?

Comparable journals include Biochemical and Biophysical Research Communications, Acta Pharmacologica Sinica, Biochemical Pharmacology, and Free Radical Biology and Medicine. Compare their scores, acceptance times, and costs in the recommended alternatives on this page before choosing where to submit.

How do I submit a paper to Biochimica Et Biophysica Acta-Molecular Basis of Disease?

Most Elsevier and Cell Press journals take submissions through Editorial Manager; each journal has its own site, reached from Submit your article on the journal homepage. Before submitting, check the scope, follow the author guidelines for article type, length, and required statements, and prepare a cover letter. Accepted papers took a median of 138 days from submission to acceptance in recent PubMed records.

Cite an article from this journal
Back to Search